A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: NNC0268-0965;   Drug: Insulin glargine;   Drug: Placebo (NNC0268-0965);   Drug: Placebo (insulin glargine) Sponsor:   Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials